Penrose TherapeuTx Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Penrose TherapeuTx's estimated annual revenue is currently $2.4M per year.(i)
  • Penrose TherapeuTx's estimated revenue per employee is $201,000

Employee Data

  • Penrose TherapeuTx has 12 Employees.(i)
  • Penrose TherapeuTx grew their employee count by 0% last year.

Penrose TherapeuTx's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Research Scientist IReveal Email/Phone
5
Principal Scientist, Analytical ChemistryReveal Email/Phone
6
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$67.1M2676%$10.8MN/A
#2
$7.8M398%N/AN/A
#3
$5M254%N/AN/A
#4
$12.7M63-6%N/AN/A
#5
$16.5M82-4%N/AN/A
#6
$59.5M2967%N/AN/A
#7
$96.2M34229%$764.2MN/A
#8
$6.8M3410%N/AN/A
#9
$5.4M27-4%N/AN/A
#10
$8.2M415%N/AN/A
Add Company

What Is Penrose TherapeuTx?

Penrose TherapeuTx is a U.S.-based pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers. Penrose has pioneered the development of a novel Mitochondrial Modifying Agent (MMA) therapeutic platform designed to generate therapies for difficult to treat cancers through a unique cooperative mechanism of action. Our approach has potential broad applicability across both hematologic and solid tumors.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$2.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M120%N/A
#2
$35M1250%N/A
#3
$1M129%N/A
#4
$1.4M12N/AN/A
#5
$1.6M13-7%N/A